SCHEMBL8073660

SCHEMBL8073660

COc1cccc2c(O)nc(-c3cccs3)nc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
MAPT P10636 6/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
LMNA P02545 4/20 0.44
ALDH1A1 P00352 4/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
HTT P42858 3/20 0.44
MAPK1 P28482 2/20 0.44
HPGD P15428 2/20 0.44
ABCB1 P08183 1/20 0.44
ABCC1 P33527 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
RPS6KB2 Q9UBS0 2/20 0.43
IDO1 P14902 1/20 0.43
TDO2 P48775 1/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
ADORA3 P0DMS8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8070579 0.84 KDM4E (0.44) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL8068659 0.81 ALDH1A1 (0.47) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL8070339 0.78 RPS6KB2 (0.57) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL8070472 0.78 XPO1 (0.58) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL2214657 0.77 PDE10A (0.52) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL7304349 0.77 RAB9A (0.47) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL15857826 0.75 KDM4E (0.45) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL8059658 0.72 MAPT (0.61) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL22805746 0.72 ADORA2A (0.50) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL15268291 0.72 KDM4E (0.49) KDM4EMAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150372-A IMMUNOINFLAMMATORY AND AUTOIMMUNE DISEASES; BLOCKING INTRACELLULAR SIGNAL TRANSDUCTION AND ACTIVATION OF TRANSCRIPTION FACTORS; KINASE INHIBITORS; ANTIARTHRITIC, ISCHEMIC AGENTS, MULTIPLE SCLEROSIS, TRANSPLANT REJECTION SIGNAL PHARMACEUTICALS, INC. (US) 2000-11-21 US disclosed
US-5939421-A TREATMENT OF IMMUNOINFLAMMATORY AND AUTOIMMUNE DISEASES SUCH AS RHEUMATOID ARTHRITIS, TRANSPLANT REJECTION; INHIBIT KINASE(S) THAT REGULATE ACTIVATION OF TRANSCRIPTION FACTORS TO PREVENT PRODUCTION OF INFLAMMATORY PROTEINS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-17 US disclosed
WO-1999001441-A1 QUINAZOLINE ANALOGS AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1999-01-14 WO disclosed